154 related articles for article (PubMed ID: 12640314)
21. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3' mismatches in forward and reverse primers.
Koss K; Fanning GC; Welsh KI; Jewell DP
Genes Immun; 2000 Jun; 1(5):321-4. PubMed ID: 11196693
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in interleukin-10 gene and risk of oral cancer.
Yao JG; Gao LB; Liu YG; Li J; Pang GF
Clin Chim Acta; 2008 Feb; 388(1-2):84-8. PubMed ID: 17980158
[TBL] [Abstract][Full Text] [Related]
23. IL-10 polymorphism is associated with increased incidence of severe sepsis.
Shu Q; Fang X; Chen Q; Stuber F
Chin Med J (Engl); 2003 Nov; 116(11):1756-9. PubMed ID: 14642153
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
Crilly A; Hamilton J; Clark CJ; Jardine A; Madhok R
Rheumatology (Oxford); 2003 Nov; 42(11):1295-8. PubMed ID: 12867583
[TBL] [Abstract][Full Text] [Related]
25. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
26. New polymorphisms in the IL-10 promoter region.
D'Alfonso S; Rampi M; Rolando V; Giordano M; Momigliano-Richiardi P
Genes Immun; 2000 Feb; 1(3):231-3. PubMed ID: 11196718
[TBL] [Abstract][Full Text] [Related]
27. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
[TBL] [Abstract][Full Text] [Related]
28. [Polymorphism of interleukin-10 gene promoter and its association with susceptibility to chronic obstructive pulmonary disease in Chinese Han people].
Hu RC; Xu YJ; Zhang ZX; Xie JG
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):504-7. PubMed ID: 14669219
[TBL] [Abstract][Full Text] [Related]
29. Association study of IL-10 and IFN-gamma gene polymorphisms in Iranian women with preeclampsia.
Kamali-Sarvestani E; Kiany S; Gharesi-Fard B; Robati M
J Reprod Immunol; 2006 Dec; 72(1-2):118-26. PubMed ID: 16863661
[TBL] [Abstract][Full Text] [Related]
30. Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency.
Cataldo F; Lio D; Marino V; Scola L; Crivello A; Mulè AM; Corazza GR;
Am J Gastroenterol; 2003 Apr; 98(4):850-6. PubMed ID: 12738467
[TBL] [Abstract][Full Text] [Related]
31. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
Zhang PA; Wu JM; Li Y; Yang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
[TBL] [Abstract][Full Text] [Related]
32. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs.
López P; Gómez J; Mozo L; Gutiérrez C; Suárez A
Arthritis Res Ther; 2006; 8(2):R42. PubMed ID: 16507146
[TBL] [Abstract][Full Text] [Related]
33. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
[TBL] [Abstract][Full Text] [Related]
34. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes.
Takahashi N; Akahoshi M; Matsuda A; Ebe K; Inomata N; Obara K; Hirota T; Nakashima K; Shimizu M; Tamari M; Doi S; Miyatake A; Enomoto T; Nakashima H; Ikezawa Z; Shirakawa T
Hum Mol Genet; 2005 Nov; 14(21):3149-59. PubMed ID: 16159888
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
[TBL] [Abstract][Full Text] [Related]
36. A base substitution in the interleukin-10 (IL-10) promoter between Sp1 and ets-1 binding sites is not associated with variation of IL-10 levels.
Jourdan-Le Saux C; Bollt O; Orozco C; Concepcion J; Yamaga K; Yamamoto F; Haymer D; Tam EK
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1109-15. PubMed ID: 14682393
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians.
Chatterjee R; Batra J; Kumar A; Mabalirajan U; Nahid S; Niphadkar PV; Ghosh B
Clin Exp Allergy; 2005 Jul; 35(7):914-9. PubMed ID: 16008678
[TBL] [Abstract][Full Text] [Related]
38. TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease.
Seifart C; Dempfle A; Plagens A; Seifart U; Clostermann U; Müller B; Vogelmeier C; von Wichert P
Tissue Antigens; 2005 Jan; 65(1):93-100. PubMed ID: 15663746
[TBL] [Abstract][Full Text] [Related]
39. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
Schippers EF; van 't Veer C; van Voorden S; Martina CA; Huizinga TW; le Cessie S; van Dissel JT
Cytokine; 2005 Mar; 29(5):215-28. PubMed ID: 15760678
[TBL] [Abstract][Full Text] [Related]
40. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
